[1] Pfaller MA,Diekema DJ.Epidemiolngy of invasive candidasis a persistent public health problem[J] Clin Microbial Bey,2007,20(1):133-163. [2] ARTEMIS念珠菌属耐药性监测协作组,朱德妹,张婴元,等.中国5所医院念珠菌属对氟康唑和伏立康唑的耐药性监测 J] 中国感染与化疗杂志,2007,7(1):14-18. [3] Richardson M,Lass-Florl C.Changing epidemiology of systemic fungal infections[J] Clin Mcrobiol Infect,2008,14(suppl4):5-24. [4] 中华内科杂志编辑委员会.侵袭性肺部真菌感染的诊断标准与治疗原则(草案)[J] 中华内科杂志,2006,45(8):697-701. [5] 中华内科杂志编辑委员会.血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(修订版)[J] 中华内科杂志,2007,46(7):607-611. [6] 陈兴,侯天文,白云,等.住院患者念珠菌菌尿的调查[J] 中国感染与化疗杂志,2009,9(5):377-380. [7] 王晓阳,赵作涛,李若瑜.深部真菌感染的诊断进展[J] 中国真菌学杂志,2008,3(6):368-371. [8] Eloy O,Blanc V,Pina P.Epidemiology of candidemia:results of one month French hospitals-based survillanee study in2004[J] Pathol Biol(Paris),2006,54(8-9):523-530. [9] 程旭萍,章云涛,方强.2002~2006年浙医一院重症监护室真菌流行病学调查[J] 中国急救医学,2009,29(1):13-16. [10] Ruan SY,Lee LN,Jerng JS.Candida glabrata fungaemia in intensive care units[J] Clin Microbiol Infect,2008,14(2):136-140. [11] Magill SS,Shields C,Sears CL.Triazole cross-resistance among Candida app.:case report,occurrence among bloodstream isolates,and implications for antifungal therapy[J] J Clin Microbiol,2006,44(2):529-535. [12] ManzoniP,Leonessa M,Galletto P.Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconaole-resistant Candida subspecies[J] Pediatr Infect Dis J,2008,27(8):731-737. [13] Lin MY,Cameli Y,Zumsteg J.Priorantimirobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia:a case-caso-control study[J] Antimicrob Agents Chemother,2005,19(11):4555-4560. [14] Quindos G,Sanchez Varges LO,Villar Vidal M.Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei:a 14-year study in a Spanish tertiary medical center[J] Int J Antimicrob Agents,2008,31(3):266-271. |